GAM buys Taube Hodson Stonex

GAM buys Taube Hodson Stonex UK (HRT), an investment company that focuses on a comprehensive strategy for action. On March 31, HRT ran a fortune of about 1.78 billion GBP or CHF 2.5 billion. In its statement Monday, GAM said that this transaction, the price is not disclosed, is in line with its strategy to complement organic growth with acquisitions and engagement teams.
Subject to customary approvals from supervisory authorities, the transaction should be finalized in Q3 2016. The HRT investment team, led by four directors Cato Stonex, Mark Evans, Robert Smithson and Ali Miremadi, then will move in the offices of GAM in London and strategies will be marketed under the GAM brand.
Said in the statement, Alexander Friedman, CEO of GAM, noted that with its successes and its extensive expertise, the team HRT framework ideally with GAM, both strategically and culturally.